Jiangsu Hengrui Medicine Co., Ltd.

This study tested a new injectable medicine, HR17031, against a standard insulin (insulin glargine) in 393 adults with type 2 diabetes. Participants had not achieved good blood sugar control despite using basal insulin and metformin. The main goal was to see if HR17031 could lowe…

This study tested a combination of two drugs, SHR-1210 (given through a vein) and Apatinib (a daily pill), in 210 adults with advanced non-small cell lung cancer that had stopped responding to standard chemotherapy. The goal was to see if the combo could shrink tumors and to chec…

This study tested a new combination treatment for people with advanced liver cancer or bile duct cancer. The treatment combines an immunotherapy drug (SHR-1210) with either a targeted therapy (apatinib) or chemotherapy. The goal was to see if the combination is safe and can shrin…

This study tested whether adding the immunotherapy drug camrelizumab to standard chemotherapy, followed by camrelizumab plus another drug (apatinib), helps people with advanced stomach or gastroesophageal junction cancer live longer. The trial involved 885 adults who had not rece…

This study tested a combination of two drugs, SHR-1210 (an immunotherapy) and apatinib (a targeted therapy), in 190 adults with advanced liver cancer that did not respond to or could not tolerate prior treatment. The goal was to see if the combination could shrink tumors and cont…

This study tested whether adding rivoceranib to camrelizumab after surgery or ablation helps prevent liver cancer from returning in patients at high risk. About 251 participants received either the combination or camrelizumab alone. The main goal was to see how long patients stay…

This study tested a new medication called HRG2010 in 165 people with Parkinson's disease who experience motor fluctuations — times when their symptoms return between doses. The goal was to see if HRG2010 could reduce daily 'off' time better than a standard extended-release carbid…

This early-phase study tested a new drug called SHR-A1811 in 396 adults with advanced solid tumors that have a specific marker (HER2). The main goals were to check safety and find the right dose. Researchers also looked for signs that the drug might shrink or control tumors. This…

This study tested a new drug called HRS-9190 against a standard drug (rocuronium) to keep muscles relaxed during surgery. 103 adults having planned surgery took part. The main goal was to measure how quickly muscle function returns after the last dose. The study aims to see if HR…

This study tested a drug called remimazolam to see how well it works and how safe it is for sedating children and teenagers during surgery. About 249 young patients took part. The goal was to see if the drug could successfully start and maintain sedation while keeping side effect…

This study tested a drug called remimazolam tosilate to sedate ICU patients who need a breathing machine for three days or more. The goal was to see if the drug keeps patients at the right level of calm without needing extra sedatives. Twenty-four adults took part in this early-p…

This early-stage study tested a new drug called HR011408 in 62 healthy adults to see if it is safe and how the body processes it. The drug is being developed for diabetes, but this trial did not test if it works. Participants received single doses of two different versions of the…

This study looked at the safety of a sedative called remimazolam tosilate when used for general anesthesia and during a breathing tube procedure (bronchoscopy). Over 1,200 patients were observed in real-world medical settings in China. The main goal was to track any side effects …

This early-stage study tested a new drug called HRS-9190 in 49 healthy adults to see if it is safe and how the body processes it. The drug is designed to relax muscles, but this trial did not aim to treat any disease. Researchers measured side effects and drug levels in the blood…

This study looked at how a single dose of HR17031 moves through the body in people with mild, moderate, severe, or end-stage kidney disease compared to those with normal kidneys. A total of 24 adults with type 2 diabetes took part. The goal was to understand how kidney function a…

This study checked whether a new form of the painkiller bupivacaine (liposomal) is absorbed in the body the same way as the approved version. It involved 36 healthy adults aged 18-45. The goal was to measure drug levels in the blood, not to treat pain directly.

This study looked at how two common drugs (ritonavir and itraconazole) change the way the body processes a new experimental drug called SHR-A1811 in people with advanced HER2-positive breast cancer. Seventeen participants received the drug alone and then with each of the other me…